Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Julia M. Hammond"'
Autor:
A. Jasmine Bullard, Francesca E. Cunningham, Bryan D. Volpp, Elliott Lowy, Lauren A. Beste, Bernadette B. Heron, Mark Geraci, Julia M. Hammond, Kourtney LaPlant, Elise A. Stave, Marsha J. Turner, Meghan C. O’Leary, Michael J. Kelley, Christine M. Hunt
Publikováno v:
Hepatology Communications, Vol 2, Iss 9, Pp 1136-1146 (2018)
Hepatitis B virus (HBV) reactivation may occur with high risk immunosuppression, such as anti‐cluster of differentiation (CD)20 antibodies (Abs). Appropriate HBV prophylaxis during anti‐CD20 Ab therapy averts hepatitis, chemotherapy disruption, a
Externí odkaz:
https://doaj.org/article/f5f8e6b9ad18483d989c186a77b81343
Publikováno v:
Clinical Genitourinary Cancer. 17:419-424
Pazopanib is a protein tyrosine kinase inhibitor that limits tumor growth through angiogenesis inhibition. The use of other protein tyrosine kinase inhibitors, specifically sunitinib, within non-clear cell renal cell carcinoma (nccRCC) has led to inc
Publikováno v:
Fed Pract
BACKGROUND: New immunotherapy agents have provided additional options for the treatment of a variety of malignancies, including the programmed death 1 (PD-1) protein inhibitors nivolumab and pembrolizumab. Initial dosing was based on patient weight,
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 27(1)
Objective Chemotherapy induced peripheral neuropathy (CIPN) is an adverse effect of certain chemotherapy agents that can result in dose reductions, permanent nerve damage, and chronic pain. Although pharmacological agents have been studied in this se
Autor:
Bernadette B. Heron, Michael J. Kelley, Mark C. Geraci, Meghan C. O'Leary, A. Jasmine Bullard, Lauren A. Beste, Kourtney LaPlant, Elliott Lowy, Elise A. Stave, Christine M. Hunt, Francesca E. Cunningham, Julia M. Hammond, Bryan D. Volpp, Marsha J. Turner
Publikováno v:
Hepatology Communications
Hepatology Communications, Vol 2, Iss 9, Pp 1136-1146 (2018)
Hepatology Communications, Vol 2, Iss 9, Pp 1136-1146 (2018)
Hepatitis B virus (HBV) reactivation may occur with high risk immunosuppression, such as anti‐cluster of differentiation (CD)20 antibodies (Abs). Appropriate HBV prophylaxis during anti‐CD20 Ab therapy averts hepatitis, chemotherapy disruption, a
Publikováno v:
Annals of Allergy, Asthma & Immunology. 119:9-15
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 24(7)
Background Tumor lysis syndrome results when intracellular contents are released during cell lysis. Ibrutinib, a Bruton tyrosine kinase inhibitor, is used for the treatment of chronic lymphocytic leukemia, small lymphocytic lymphoma, Waldenström’s
Publikováno v:
Annals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology. 119(1)
Publikováno v:
Journal of Thrombosis and Thrombolysis. 11:33-37
We report here a case of recurrent venous and arterial thromboembolism, Trousseau's syndrome, in a cancer patient who developed heparin-induced thrombocytopenia. She was treated with lepirudin and after establishing the patient-specific half-life for
Publikováno v:
The Annals of pharmacotherapy. 45(1)
Objective To review clinical trials and main characteristics of everolimus, with focus on treatment of advanced renal cell carcinoma. Data Sources: Pertinent data were identified primarily through a search of MEDLINE and PubMed (1966-November 2010) u